10th RSC-BMCS Fragment-based Drug Discovery Meeting - ZoBio

In person

ZoBio is pleased to attend the RSC-BMCS Fragment-Based Drug Discovery meeting in Cambridge this September.

ZoBio will be represented by Johan Veerman | LinkedIn, Head of Chemistry, who will also present a poster entitled:

Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14

We look forward to sharing our work, exchanging ideas with the fragment-based drug discovery community, and connecting with fellow scientists in Cambridge.

Conference website

Curious to see how these approaches can support complex discovery programs? Download the poster to explore in more detail.

Download the Poster: Site-selective screening

Your name(Required)

Company(Required)

Email(Required)

Privacy(Required)

I authorize the storage and processing of my information by the Oncodesign Services-ZoBio Group so that my request can be followed up to my request and services that meet my needs can be identified. For more information, please review our privacy policy.

Email communications(Required)

I agree to receive e-mail communications from the Oncodesign Services-ZoBio Group. I understand that I can unsubscribe at any time.